Cytosorbents
CTSO • NASDAQ • Stock Fundamentals
Cytosorbents is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Phillip Chan, with a market cap of $29.0M.
Market Cap$29.0M
Employees186.0
CEOPhillip Chan
CountryUnited States of America
Healthcare
Medical - Devices
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Cytosorbents FAQ
Common questions about Cytosorbents
Cytosorbents (CTSO) has a market capitalization of $29.0M and trades on NASDAQ.
Cytosorbents has approximately 186 employees.